Welcome to our dedicated page for Chiron Real Estate news (Ticker: XRN), a resource for investors and traders seeking the latest updates and insights on Chiron Real Estate stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Chiron Real Estate's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Chiron Real Estate's position in the market.
Chiron Real Estate (NYSE:XRN) completed the $249 million acquisition of The Landing and The Riviera, two senior living communities in the Washington, DC metro area, totaling 292 homes across independent living, assisted living, and memory care.
Their seniors housing operating communities (SHOP) investments now represent about 14% of gross real estate assets, with a path to roughly 25% assuming closing of the $176 million Pinnacle acquisition and planned asset sales.
Aditxt (NASDAQ:XRN) appointed Jeffrey M. Busch as Interim CEO effective May 31, 2026, while he continues leading subsidiary Ignite Proteomics. Busch previously founded and led an NYSE-listed healthcare real estate company to over $1 billion enterprise value and ~8.5% average dividend yield.
Aditxt plans an accelerated commercialization strategy centered on Ignite's precision oncology diagnostics platform following founder Amro Albanna’s resignation from all company and subsidiary roles.
Chiron Real Estate (NYSE:XRN) appointed Charles Fitzgerald to its Board of Directors effective May 20, 2026, joining the Compensation and Nominating and Corporate Governance Committees. He beneficially owns 97,293 Chiron common shares, about $3.4 million of invested capital.
Chiron also declared its second quarter 2026 preferred dividends: $0.46875 per share on Series A and $0.50 per share on Series B, for holders of record on July 15, 2026, payable July 31, 2026.
Chiron Real Estate (NYSE: XRN) entered purchase agreements to acquire three seniors housing communities for an aggregate price of $425 million, marking its inaugural senior housing investments. Two Alexandria properties (The Landing and The Riviera) total $249 million with expected closings on or about June 1, 2026; Pinnacle North Bethesda is ~$176 million with expected closing in October 2026.
The Alexandria campus was 90% occupied (Landing) and ~20% leased (Riviera) as of April 30, 2026; Pinnacle was ~30% preleased. Greystone will manage operations; Silverstone affiliates retain oversight.
Chiron Real Estate (NYSE: XRN) entered an agreement for up to $100.0 million of delayed-draw Series C convertible perpetual preferred stock led by Maewyn Capital Partners, with all capital callable within six months of May 6, 2026. The securities pay a 6.00% cash dividend, convert at $43.00 per share, and include board appointment and redemption/conversion mechanics.
Charles P. Fitzgerald will join the board after the May 20, 2026 annual meeting; Maewyn already owns ~53,434 common shares (~$2 million invested).
Chiron Real Estate (NYSE: XRN) reported Q1 2026 results and announced strategic transactions on May 6, 2026. Key items: reported quarterly net loss of $0.7M ($0.06/sh), FFO $0.97/sh, Core FFO $1.11/sh, Same-Property Cash NOI +3.2%, 95.4% occupancy.
The company signed purchase agreements for three luxury seniors housing communities ($425M aggregate), secured a $100M convertible preferred equity commitment from Maewyn, and reduced the monthly dividend to $0.16 for Jul–Sep 2026.
Chiron Real Estate (NYSE: XRN) will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026, and will host a conference call and webcast on Thursday, May 7, 2026 at 9:00 a.m. ET.
Company executives Mark Decker Jr., Robert Kiernan, Alfonzo Leon and Danica Holley will host the call; a replay and archived webcast will be available through May 21, 2026.
Aditxt (Nasdaq: ADTX) announced Jeff Busch as CEO of its newly acquired subsidiary Ignite Proteomics on March 19, 2026. Ignite operates a commercial-stage precision oncology platform that measures active proteins to guide cancer therapy selection and has Medicare reimbursement.
Busch, founder and former CEO of Chiron Real Estate (NYSE: XRN), will lead commercial expansion and evaluate strategic growth and financing alternatives to scale revenue and pursue sustainable profitability.
Chiron Real Estate (NYSE: XRN) reported Q4 2025 results and 2026 guidance. Q4 net loss was $7.4M (loss of $0.55/share); Q4 FFO was $0.97/share (+26% YoY) and Core FFO was $1.16/share (+6.4% YoY). Same-property Cash NOI grew 5.4% and year-end occupancy was 96.0%.
Balance sheet: consolidated debt $653.9M, leverage 44.4%, weighted-average interest rate 3.74%. Capital moves: repurchased 175,634 shares for $6.0M, issued Series B preferred for $51.3M. Board moved common dividends to monthly at an unchanged annualized rate of $3.00 ($0.25/month Apr–Jun). 2026 Core FFO guidance: $4.30–$4.45.